Stay updated with breaking news from Sciences Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Resources Investment Advisors LLC. trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 96,686 shares of the medical research company’s stock after selling 3,507 shares during the period. Resources Investment Advisors […]
Connor Clark & Lunn Investment Management Ltd. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Connor Clark […]
Connor Clark & Lunn Investment Management Ltd. acquired a new position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Other institutional investors and […]
AtonRa Partners decreased its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,530 shares of the medical research company’s stock after selling 1,622 shares during the […]
Mayo Clinic increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 40.9% in the 1st quarter, Holdings Channel reports. The firm owned 5,151 shares of the medical research company’s stock after purchasing an additional 1,496 shares during the period. Exact Sciences accounts for approximately 0.3% of Mayo Clinic’s holdings, making the stock […]